Assoc Prof Dr. Dalia Abdelkader | Advanced Fiber Technologies | Women Researcher Award

University of Tanta - Egypt

Professional Profiles:

Early Academic Pursuits

Born on August 17, 1986, in Egypt, Dalia Abdelkader embarked on her academic journey with a fervent interest in pharmaceutical sciences. Her initial foray into this field was at the Faculty of Pharmacy, Tanta University, where her passion for drug delivery systems and biopharmaceutics was ignited. Abdelkader's educational path is characterized by a relentless pursuit of knowledge, culminating in her PhD from the University of Ulster in Northern Ireland, UK. Her doctoral research, focusing on the design and development of particulate carrier systems for the delivery and targeting of biotherapeutics, set the stage for her future contributions to pharmaceutical technology.

Professional Endeavors

Upon completing her PhD, Abdelkader returned to Egypt, where she has been instrumental in shaping the pharmaceutical landscape through her roles at Tanta University. As an Associate Professor of Pharmaceutical Technology, she has not only contributed to academia through teaching and curriculum development but has also taken on significant administrative responsibilities. Her roles have included Director of the Pharmaceutical Services Centre and Managing Editor of the Journal of Advanced Medical and Pharmaceutical Research (JAMPR), highlighting her multifaceted contributions to the field.

Contributions and Research Focus on Advanced Fiber Technologies

Abdelkader's research has primarily revolved around enhancing drug delivery systems, with a keen focus on bioavailability and bioequivalence studies. Her work is pivotal in the development of generic pharmaceutical products, ensuring their quality and efficacy align with or surpass existing therapeutic options. This research is not only academically significant but also has profound implications for global health, making essential medicines more accessible and affordable.

Accolades and Recognition

Her scholarly work, characterized by an H-index that reflects high citation and impact (13 on Google Scholar, 12 on Scopus, and 14 on ResearchGate), underscores the international recognition of her research contributions. These indices are testament to her relentless pursuit of excellence and her significant impact on the pharmaceutical sciences community.

Impact and Influence

Abdelkader's influence extends beyond her research. As Director of the Pharmaceutical Services Centre, she plays a crucial role in ensuring the quality of pharmaceutical products, impacting patient care directly. Her editorial role at JAMPR further amplifies her impact by facilitating the dissemination of cutting-edge research in medical and pharmaceutical sciences.

Legacy and Future Contributions

Looking forward, Abdelkader is committed to pioneering innovative solutions in pharmaceutical technology. Her vision encompasses the development of more efficient drug delivery systems and enhancing the quality of pharmaceutical education and research in Egypt and beyond. Abdelkader's dedication to her field promises to leave a lasting legacy, characterized by a stronger, more accessible pharmaceutical landscape.


Dalia Abdelkader | Advanced Fiber Technologies | Women Researcher Award

You May Also Like